ASCO 2023 Expert Report in HR positive, HER2 negative breast cancer by Catherine Harper-Wynne European Society for Medical Oncology (ESMO) 7:15 1 year ago 7 967 Далее Скачать
HER2-low breast cancer: the ESMO Expert Consensus Statements European Society for Medical Oncology (ESMO) 2:02 1 year ago 997 Далее Скачать
ESMO 2023 Breast Cancer Highlights – Keynote 756, TROPION-Breast01, Keynote 52 | Onc Brothers OncBrothers: Practice-Changing Cancer Discussions 13:51 1 year ago 2 164 Далее Скачать
Breast Cancer ESMO 2024 Highlights: Key Studies Discussed NATALEE, KEYNOTE 522, DESTINY-Breast12 OncBrothers: Practice-Changing Cancer Discussions 18:38 3 months ago 3 862 Далее Скачать
Advancements in metastatic ER+ breast cancer at ESMO Breast 2024 VJOncology 1:10 6 months ago 234 Далее Скачать
How to sequence ADCs in breast cancer? | ESMO 2023 Breast Cancer Highlights OncBrothers: Practice-Changing Cancer Discussions 0:59 1 year ago 206 Далее Скачать
Updates in metastatic triple-negative breast cancer at ESMO 2023 VJOncology 2:14 1 year ago 758 Далее Скачать
2023 What Changes Monday Morning? | ESMO Breast Cancer Webinar Total Health | Oncology 1:35:10 1 year ago 2 829 Далее Скачать
#ESMO22 Highlights on abemaciclib + NSAI in HR+/HER2- advanced breast cancer: The MONARCH 3 study European Society for Medical Oncology (ESMO) 2:37 2 years ago 2 045 Далее Скачать
Expert report on tackling resistance to CDK4/6 inhibitors in ER+/HER2-metastatic breast cancer European Society for Medical Oncology (ESMO) 4:50 2 years ago 1 388 Далее Скачать
Challenges in identifying predictive markers to ICIs in triple-negative breast cancer VJOncology 1:02 1 year ago 80 Далее Скачать
HER2+ and PIK3DA-mutated breast cancer updates from ESMO Breast 2024 VJOncology 1:27 6 months ago 156 Далее Скачать
